Glofitamab (Anti-CD20 & CD3)
Product Specifications
CAS Number
2229047-91-8
Synonyms
RG6026, RO7082859
SKU
C00881-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Glofitamab is a T-cell–engaging bispecific antibody that targets CD3 and CD20, demonstrating significant antitumor activity and durable responses in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) . It works by binding to CD20 on B cells and CD3 on T cells, promoting T-cell-mediated lysis of malignant B cells. MW: 170.28 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
039813-ML750 100 µL
PDE8B, ID (PDE8B, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B, Cell proliferation-inducing gene 22 protein) (MaxLight 750) discontinued
Ask
View Details